UB Paderborn / Katalog / Suche / in CDI

Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo

International journal of pharmaceutics, 2004-06, Vol.278 (1), p.119-131

2004

Link zum Volltext

Verfügbarkeit prüfen

Gastrointestinal absorption of drugs: methods and studies

Fundamental & clinical pharmacology, 1999-01, Vol.13 (2), p.154-168

1999

Link zum Volltext

Verfügbarkeit prüfen

Population Pharmacokinetics of Ceftazidime in Intensive Care Unit Patients: Influence of Glomerular Filtration Rate, Mechanical Ventilation, and Reason for Admission

Antimicrobial Agents and Chemotherapy, 2009-10, Vol.53 (10), p.4483-4489

2009

Link zum Volltext

Verfügbarkeit prüfen

Tobramycin disposition in ICU patients receiving a once daily regimen: population approach and dosage simulations

British journal of clinical pharmacology, 2011-01, Vol.71 (1), p.61-71

2011

Link zum Volltext

Verfügbarkeit prüfen

The influence of weightlessness on pharmacokinetics

Fundamental & clinical pharmacology, 2005-12, Vol.19 (6), p.625-636

2005

Link zum Volltext

Verfügbarkeit prüfen

The roles of P-glycoprotein and intracellular metabolism in the intestinal absorption of methadone: in vitro studies using the rat everted intestinal sac

Fundamental & clinical pharmacology, 1999-08, Vol.13 (4), p.494-500

1999

Link zum Volltext

Verfügbarkeit prüfen

Optimizing ciprofloxacin dosing in intensive care unit patients through the use of population pharmacokinetic-pharmacodynamic analysis and Monte Carlo simulations

Journal of antimicrobial chemotherapy, 2011-08, Vol.66 (8), p.1798-1809

2011

Link zum Volltext

Verfügbarkeit prüfen

A whole-body physiologically based pharmacokinetic (WB-PBPK) model of ciprofloxacin: a step towards predicting bacterial killing at sites of infection

Journal of pharmacokinetics and pharmacodynamics, 2017-04, Vol.44 (2), p.69-79

2017

Link zum Volltext

Verfügbarkeit prüfen

Determination of plasma unbound fraction of voriconazole in patients treated with a prophylactic or a curative treatment

Therapeutic drug monitoring, 2014-12, Vol.36 (6), p.752

2014

Link zum Volltext

Verfügbarkeit prüfen

Assessment of renal function in clinical practice at the bedside of burn patients

British journal of clinical pharmacology, 2007-05, Vol.63 (5), p.583-594

2007

Link zum Volltext

Verfügbarkeit prüfen

Ceftazidime dosage regimen in intensive care unit patients: from a population pharmacokinetic approach to clinical practice via Monte Carlo simulations

British journal of clinical pharmacology, 2012-04, Vol.73 (4), p.588-596

2012

Link zum Volltext

Verfügbarkeit prüfen

Medical and pharmacological approach to adjust the salbutamol anti-doping policy in athletes

Respiratory research, 2015-12, Vol.16 (155), p.155, Article 155

2015

Link zum Volltext

Verfügbarkeit prüfen

Is Once-Daily Mesalazine Equivalent to the Currently Used Twice-Daily Regimen? A Study Performed in 30 Healthy Volunteers

Journal of clinical pharmacology, 2007-03, Vol.47 (3), p.334-342

2007

Link zum Volltext

Verfügbarkeit prüfen

Ciprofloxacin use in critically ill patients: pharmacokinetic and pharmacodynamic approaches

International journal of antimicrobial agents, 2008-12, Vol.32 (6), p.505-510

2008

Link zum Volltext

Verfügbarkeit prüfen

A population pharmacokinetic approach to ceftazidime use in burn patients: influence of glomerular filtration, gender and mechanical ventilation

British journal of clinical pharmacology, 2007-07, Vol.64 (1), p.27-35

2007

Link zum Volltext

Verfügbarkeit prüfen

Modification of aflatoxin B1 and ochratoxin A toxicokinetics in rats administered a yeast cell wall preparation

Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment, 2010-08, Vol.27 (8), p.1153-1160

2010

Link zum Volltext

Verfügbarkeit prüfen

Influence of renal function on trough serum concentrations of piperacillin in intensive care unit patients

Intensive care medicine, 2006-12, Vol.32 (12), p.2063-2066

2006

Link zum Volltext

Verfügbarkeit prüfen

Tuberculose : intérêt du dosage de l’isoniazide dans la prévention des effets hépatotoxiques

Therapie, 2014-11, Vol.69 (6), p.509-516

2014

Link zum Volltext

Verfügbarkeit prüfen

Tuberculosis: relevance of isoniazid dosage in prevention of liver side effects

Therapie, 2014-11, Vol.69 (6), p.509

2014

Link zum Volltext

Verfügbarkeit prüfen

Risk of emergence of Pseudomonas aeruginosa resistance to β-lactam antibiotics in intensive care units

Critical care medicine, 2006-06, Vol.34 (6), p.1636-1641

2006

Link zum Volltext

Verfügbarkeit prüfen

Prediction of Carboplatin Clearance From Standard Morphological and Biological Patient Characteristics

JNCI : Journal of the National Cancer Institute, 1995-04, Vol.87 (8), p.573-580

1995

Link zum Volltext

Verfügbarkeit prüfen

The metabolism of midazolam and comparison with other CYP enzyme substrates during intestinal absorption: in vitro studies with rat everted gut sacs

Journal of pharmacy & pharmaceutical sciences, 2007, Vol.10 (1), p.26-36

2007

Link zum Volltext

Verfügbarkeit prüfen

Localisation of drug permeability along the rat small intestine, using markers of the paracellular, transcellular and some transporter routes

European journal of pharmaceutical sciences, 2004-12, Vol.23 (4), p.385-391

2004

Link zum Volltext

Verfügbarkeit prüfen

Clinical pharmacokinetics of acamprosate

Clinical pharmacokinetics, 1998-11, Vol.35 (5), p.331-345

1998

Link zum Volltext

Verfügbarkeit prüfen

Influence of Simulated Weightlessness on the Intramuscular and Oral Pharmacokinetics of Promethazine in 12 Human Volunteers

Journal of clinical pharmacology, 2006-09, Vol.46 (9), p.1008-1016

2006

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo

Gastrointestinal absorption of drugs: methods and studies

Population Pharmacokinetics of Ceftazidime in Intensive Care Unit Patients: Influence of Glomerular Filtration Rate, Mechanical Ventilation, and Reason for Admission

Tobramycin disposition in ICU patients receiving a once daily regimen: population approach and dosage simulations

The influence of weightlessness on pharmacokinetics

The roles of P-glycoprotein and intracellular metabolism in the intestinal absorption of methadone: in vitro studies using the rat everted intestinal sac

Optimizing ciprofloxacin dosing in intensive care unit patients through the use of population pharmacokinetic-pharmacodynamic analysis and Monte Carlo simulations

A whole-body physiologically based pharmacokinetic (WB-PBPK) model of ciprofloxacin: a step towards predicting bacterial killing at sites of infection

Determination of plasma unbound fraction of voriconazole in patients treated with a prophylactic or a curative treatment

Assessment of renal function in clinical practice at the bedside of burn patients

Ceftazidime dosage regimen in intensive care unit patients: from a population pharmacokinetic approach to clinical practice via Monte Carlo simulations

Medical and pharmacological approach to adjust the salbutamol anti-doping policy in athletes

Is Once-Daily Mesalazine Equivalent to the Currently Used Twice-Daily Regimen? A Study Performed in 30 Healthy Volunteers

Ciprofloxacin use in critically ill patients: pharmacokinetic and pharmacodynamic approaches

A population pharmacokinetic approach to ceftazidime use in burn patients: influence of glomerular filtration, gender and mechanical ventilation

Modification of aflatoxin B1 and ochratoxin A toxicokinetics in rats administered a yeast cell wall preparation

Influence of renal function on trough serum concentrations of piperacillin in intensive care unit patients

Tuberculose : intérêt du dosage de l’isoniazide dans la prévention des effets hépatotoxiques

Tuberculosis: relevance of isoniazid dosage in prevention of liver side effects

Risk of emergence of Pseudomonas aeruginosa resistance to β-lactam antibiotics in intensive care units

Prediction of Carboplatin Clearance From Standard Morphological and Biological Patient Characteristics

The metabolism of midazolam and comparison with other CYP enzyme substrates during intestinal absorption: in vitro studies with rat everted gut sacs

Localisation of drug permeability along the rat small intestine, using markers of the paracellular, transcellular and some transporter routes

Clinical pharmacokinetics of acamprosate

Influence of Simulated Weightlessness on the Intramuscular and Oral Pharmacokinetics of Promethazine in 12 Human Volunteers

Suchergebnisse filtern